BioPace
PrivateLast Round
Grant
Apr 1, 2020
Est. Valuation
$3M
Total Funding Raised
$270,000
Company Overview
BioPace is a biotechnology company developing a hardware-free biological pacemaker technology to complement or replace traditional implantable electronic pacemakers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioPace Comparables
Compare BioPace with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PacingCure B.V. | 82% | |
| Cortex, Inc. | 64% | |
| CAIRDAC | 63% |
BioPace Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 1, 2020 | ||||
| Accelerator | Nov 1, 2013 |
BioPace Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leonhardt Ventures | Accelerator |
| Cal-X Stars Business Accelerator | Accelerator |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2013
$270K round led by Leonhardt Ventures.
BioPace Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioPace's valuation, stock price, and market status.
Is BioPace a public or private company?
BioPace is a private company.
What is the current stock price of BioPace?
BioPace is a private company with no public stock price. Caplight tracks BioPace's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is BioPace worth (valuation)?
BioPace's valuation is estimated at $3.0M based on funding round data.
Can I buy BioPace stock?
BioPace shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioPace's last funding round?
BioPace's most recent funding round was Grant on November 1, 2013.
Who are the main investors in BioPace?
Key investors in BioPace include Leonhardt Ventures.
Will BioPace IPO soon?
No public IPO plans have been announced for BioPace.
How can I track BioPace secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioPace's secondary market activity and sign up for updates.